Eligibility:
- The article must be a peer-reviewed, original research article published during the period from 2024 to 2025 (i.e., articles in volumes published in 2024-2025).
- The corresponding author must be affiliated with a Finnish university.
- Any author may submit the nomination on behalf of all co-authors.
Please include the following information in your nomination:
- Full names and contact information of all authors.
- Title of the article and a link to its electronic version.
- Full bibliographic citation of the article (including title, authors, journal name, year, volume, issue, pages, and DOI).
- A description (max. 150 words) highlighting the article’s key contributions and merits from a pharmaceutical perspective. This should address the novelty, significance, and originality of the research.